|
Volume
20 Number 3
31 March 2018
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
20, Year 2018 >
Number 3, 31 March
|
|
|
|
|
|
[No authors listed]
Medulloblastoma
Circulating Tumor Cells Form Leptomeningeal Metastases.
Cancer
Discov. 2018 Mar 2, 2018;8(4):383→.
doi: 10.1158/2159-8290.CD-RW2018-035→.
PMID: 29500296→.
Comment. ˍ
Refers
to:
Garzia
L et al., A Hematogenous Route for Medulloblastoma Leptomeningeal
Metastases. Cell. 2018 Feb 22, 2018;172(5):1050-1062.e14→.
doi: 10.1016/j.cell.2018.01.038→.
PMID: 29474906→.
Laboratory
investigation.
ˍ
Corrected
online 2018 Mar 7.
|
|
|
|
Broniscer A, Jia S, Mandrell B, Hamideh D, Huang J, Onar-Thomas A,
Gajjar A, Raimondi SC, Tatevossian RG, Stewart CF.
Phase
1 trial, pharmacokinetics, and pharmacodynamics of dasatinib
combined with crizotinib in children with recurrent or progressive
high-grade and diffuse intrinsic pontine glioma.
Pediatr
Blood Cancer. 2018 Mar 7, 2018;65(7):e27035→.
doi: 10.1002/pbc.27035→.
PMID: 29512900→.
Interventional study. ˍ
|
|
|
|
Yang DY, Bu XY, Zhou ZL, Yan ZY, Ma CX, Qu MQ, Zhao YW, Kong LF,
Wang YW, Luo JC.
Enhanced antitumor
effects of radiotherapy combined local nimustine delivery
rendezvousing with oral temozolomide chemotherapy in glioblastoma
patients.
J Cancer Res Ther. 2018 Mar 8,
2018;14(1):78-83→.
doi: 10.4103/jcrt.JCRT_844_17→.
PMID: 29516964→.
Observational study. ˍ
|
|
|
|
Matsuda M, Ishikawa E, Yamamoto T, Hatano K, Joraku A, Iizumi Y,
Masuda Y, Nishiyama H, Matsumura A.
Potential
use of prostate specific membrane antigen (PSMA) for detecting the
tumor neovasculature of brain tumors by PET imaging with
89Zr-Df-IAB2M
anti-PSMA minibody.
J Neurooncol. 2018 Mar 9,
2018;138(3):581-589→.
doi: 10.1007/s11060-018-2825-5→.
PMID: 29524126→.
Laboratory investigation. ˍ
|
|
|
|
Fernandes Cabral DT, Zenonos GA, Nuñez M, Celtikci P,
Snyderman C, Wang E, Gardner PA, Fernandez-Miranda JC.
Endoscopic
Endonasal Transclival Approach for Resection of a Pontine Glioma:
Surgical Planning, Surgical Anatomy, and Technique.
Oper
Neurosurg (Hagerstown). 2018 Mar 12, 2018;15(5):589-599→.
doi: 10.1093/ons/opy005→.
PMID: 29538708→.
Case report. ˍ
|
|
|
|
Smit M, Van Stralen HE, Van den Munckhof B, Snijders TJ, Dijkerman
HC.
The man who lost his body:
Suboptimal multisensory integration yields body awareness problems
after a right temporoparietal brain tumour.
J
Neuropsychol. 2018 Mar 12, 2019;13(3):603-612→.
doi: 10.1111/jnp.12153→.
PMID: 29532598→.
Case report. ˍ
|
|
|
|
Rammo R, Asmaro K, Schultz L, Scarpace L, Siddiqui S, Walbert T,
Kalkanis S, Lee I.
The safety of
magnetic resonance imaging-guided laser interstitial thermal
therapy for cerebral radiation necrosis.
J
Neurooncol. 2018 Mar 13, 2018;138(3):609-61→.
doi: 10.1007/s11060-018-2828-2→.
PMID: 29536345→.
Observational study.
ˍ
|
|
|
|
Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE,
Delbridge C, Gerhardt J, Zimmer C, Meyer B, Kirschke JS,
Boeckh-Behrens T, Wiestler B, Gempt J.
Retrospective
Analysis of Radiological Recurrence Patterns in Glioblastoma,
Their Prognostic Value And Association to Postoperative Infarct
Volume.
Sci Rep. 2018 Mar 14, 2018;8(1):4561→.
doi: 10.1038/s41598-018-22697-9→.
PMID: 29540809→.
Observational study. ˍ
|
|
|
|
Guan Y, Chen J, Zhan Y, Lu H.
Effects
of dexamethasone on C6 cell proliferation, migration and invasion
through the upregulation of AQP1.
Oncol Lett. 2018
Mar 15, 2018;15(5):7595-7602→.
doi: 10.3892/ol.2018.8269→.
PMID: 29740485→.
Laboratory investigation. ˍ
|
|
|
|
Mata-Mbemba D, Zapotocky M, Laughlin S, Taylor MD, Ramaswamy V,
Raybaud C.
MRI Characteristics of
Primary Tumors and Metastatic Lesions in Molecular Subgroups of
Pediatric Medulloblastoma: A Single-Center Study.
AJNR
Am J Neuroradiol. 2018 Mar 15, 2018;39(5):949-955→.
doi: 10.3174/ajnr.A5578→.
PMID: 29545246→.
Observational study.
ˍ
|
|
|
|
Weinberg BD, Boreta L, Braunstein S, Cha S.
Location
of subventricular zone recurrence and its radiation dose predicts
survival in patients with glioblastoma.
J
Neurooncol. 2018 Mar 15, 2018;138(3):549-556→.
doi: 10.1007/s11060-018-2822-8→.
PMID: 29546530→.
Observational study.
ˍ
|
|
|
|
Kuga D, Hata N, Akagi Y, Amemiya T, Sangatsuda Y, Hatae R,
Yoshimoto K, Mizoguchi M, Iihara K.
The
Effectiveness of Salvage Treatments for Recurrent Lesions of
Oligodendrogliomas Previously Treated with Upfront
Chemotherapy.
World Neurosurg. 2018 Mar 16,
2018;114:e735-e742→.
doi: 10.1016/j.wneu.2018.03.069→.
PMID: 29551724→.
Observational study.
ˍ
|
|
|
|
Wang
C, Sun W, Kirkpatrick J, Chang Z, Yin FF.
Assessment
of concurrent stereotactic radiosurgery and bevacizumab treatment
of recurrent malignant gliomas using multi-modality MRI imaging
and radiomics analysis.
J
Radiosurg SBRT. 2018 [Mar 16], 2018;5(3):171-181→.
PMID:
29988289→.
Observational
study. ˍ
|
|
|
|
Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi
M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T,
Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y,
Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M,
Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo
T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A,
Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S;
Members of Japan Clinical Oncology Group Brain Tumor Study Group
(JCOG-BTSG).
JCOG0911 INTEGRA
study: a randomized screening phase II trial of interferonβ
plus temozolomide in comparison with temozolomide alone for newly
diagnosed glioblastoma.
J
Neurooncol. 2018 Mar 20,
2018;138(3):627-636→.
doi: 10.1007/s11060-018-2831-7→.
PMID: 29557060→.
Interventional study. ˍ
|
|
|
|
Liu Y, Feng F, Ji P, Liu B, Ge S, Yang C, Lou M, Liu J, Li B, Gao
G, Qu Y, Wang L.
Improvement of
health related quality of life in patients with recurrent glioma
treated with bevacizumab plus daily temozolomide as the salvage
therapy.
Clin Neurol Neurosurg. 2018 Mar
27;169:64-70→.
doi: 10.1016/j.clineuro.2018.03.026→.
PMID: 29631109→.
Observational
study. ˍ
|
|
|
|
Nassiri F, Aldape K, Zadeh G.
The
multiforme of glioblastoma.
Neuro Oncol. 2018 Mar
27, 2018;20(4):437-438→.
doi: 10.1093/neuonc/noy025→.
PMID: 29596671→.
Comment. ˍ
Refers to:
Mahlokozera
T,et al.,Biological and therapeutic implications of multisector
sequencing in newly diagnosed glioblastoma. Neuro Oncol. 2017 Dec
13, 2018;20(4):472-483→.
doi: 10.1093/neuonc/nox232→.
PMID: 29244145→.
Laboratory
investigation.
ˍ
|
|
|
|
Ostrom QT, Rubin JB, Lathia JD, Berens ME, Barnholtz-Sloan JS.
Females have the survival advantage
in glioblastoma.
Neuro Oncol. 2018 Feb 21,
2018;20(4):576-577→.
doi: 10.1093/neuonc/noy002→.
PMID: 29474647→.
Letter to the Editor / Observational study. ˍ
|
|
|
|
|
|
|
|
|
